A Low-Cost Balance Training Platform Using Augmented Reality in Neurorehabilitation: a Usability Study
Hospital Universitari Vall d'Hebron Research Institute
15 participants
Aug 6, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to assess the Usability, adherence, acceptance, and security of an augmented reality platform for balance training in patients with balance disorders due to degenerative injuries or cerebrovascular diseases. The main questions it aims to answer are: * Is the augmented reality system usable, acceptable, and safe with good adherence? * Does the system improve the balance in our population? * Participants will be asked to assist at Vall d'Hebrón Hospital, where patients will undergo balance training under the supervision of a physiotherapist three days a week for four weeks. * If the patients meet the inclusion criteria, the intervention will be extended for two more weeks at home.
Eligibility
Inclusion Criteria9
- Balance impairment due cerebrovascular diseases or neurodegenerative diseases.
- Being able to mantain standing for 2 minuts without assistance.
- Berg scale ≥21
- Age ≥18
- Signing informed consent
- To have a training partner during the exercises at home.
- No fall attempt during hospital intervention
- No have enough space to train safely at their home.
- Being familiar with technological devices such a laptop, tablets or inteligent cellphones.
Exclusion Criteria6
- The presence of a condition or abnormality that could compromise the patient's safety.
- Severe cognitive impairments tha prevent the execution of the xperiment (MoCA <19)
- Presence of sensory aphasia.
- Diagnostic of conduct disorders.
- Presence of severe neglect.
- Spasticity =4 in MAS lower limb.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention will be carried out in two phases. The first phase will take place at Vall d\&#39;Hebron Hospital, where patients will undergo balance training under the supervision of a physiotherapist. The scheduled dose will be 60 minutes daily, three days a week for four weeks. If the patients meet the inclusion criteria, the intervention will be extended for two more weeks at home. For this task, the involvement of a family member as a training partner will be essential. Relatives will receive training on using the system in the hospital and must be present whenever the patient undergoes the training at home. Three assessments will be carried out during the six weeks of the study. At the beginning of the intervention ("Day 0" ), a second is once the hospital intervention has been carried out ("Week 4" ), and the last is once the home intervention has been carried out ("Week 6").
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06627387